Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Valla

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Hepatology (Baltimore, Md.)|December 31, 2008
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patientsRami Moucari, Vincent Mackiewicz, Olivier Lada, et al.
Journal of Hepatology|April 21, 2009
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up studyRami Moucari, Anneke Korevaar, Olivier Lada, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 27, 2007
Cytokine--chemokine and apoptotic signatures in patients with hepatitis CManuela G Neuman, Jean-Pierre Benhamou, Patrick Marcellin, et al.
Endoscopy|March 3, 2015
Screening of esophageal varices by esophageal capsule endoscopy: results of a French multicenter prospective studySylvie Sacher-Huvelin, Paul Calès, Christophe Bureau, et al.
European Journal of Gastroenterology & Hepatology|December 3, 2019
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetesThierry Poynard, Valentina Peta, Olivier Deckmyn, et al.
Journal of Hepatology|March 30, 2010
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosisAna-Carolina Cardoso, Rami Moucari, Claudio Figueiredo-Mendes, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndromeAurélie Plessier, Annie Sibert, Yann Consigny, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 23, 2011
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation systemClaire Francoz, Jacques Belghiti, Denis Castaing, et al.
The American Journal of Pathology|June 7, 2011
Changes in autophagic response in patients with chronic hepatitis C virus infectionPierre-Emmanuel Rautou, Dominique Cazals-Hatem, Gérard Feldmann, et al.
Gastroenterology|January 1, 2008
Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosisRami Moucari, Tarik Asselah, Dominique Cazals-Hatem, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Hepatology (Baltimore, Md.)|December 31, 2008
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patientsRami Moucari, Vincent Mackiewicz, Olivier Lada, et al.
Journal of Hepatology|April 21, 2009
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up studyRami Moucari, Anneke Korevaar, Olivier Lada, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 27, 2007
Cytokine--chemokine and apoptotic signatures in patients with hepatitis CManuela G Neuman, Jean-Pierre Benhamou, Patrick Marcellin, et al.
Endoscopy|March 3, 2015
Screening of esophageal varices by esophageal capsule endoscopy: results of a French multicenter prospective studySylvie Sacher-Huvelin, Paul Calès, Christophe Bureau, et al.
European Journal of Gastroenterology & Hepatology|December 3, 2019
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetesThierry Poynard, Valentina Peta, Olivier Deckmyn, et al.
Journal of Hepatology|March 30, 2010
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosisAna-Carolina Cardoso, Rami Moucari, Claudio Figueiredo-Mendes, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndromeAurélie Plessier, Annie Sibert, Yann Consigny, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 23, 2011
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation systemClaire Francoz, Jacques Belghiti, Denis Castaing, et al.
The American Journal of Pathology|June 7, 2011
Changes in autophagic response in patients with chronic hepatitis C virus infectionPierre-Emmanuel Rautou, Dominique Cazals-Hatem, Gérard Feldmann, et al.
Gastroenterology|January 1, 2008
Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosisRami Moucari, Tarik Asselah, Dominique Cazals-Hatem, et al.
Pageof 17